{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:19:23Z","timestamp":1783732763259,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jiac.2015.04.015","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T02:18:42Z","timestamp":1431569922000},"page":"575-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Penetration of piperacillin\u2013tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics"],"prefix":"10.1016","volume":"21","author":[{"given":"Ikuo","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuro","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kogenta","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genya","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Kajikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Zennami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Kanao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Tobiume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Narushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sumitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2015.04.015_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14787210.5.3.365","article-title":"Piperacillin\u2013tazobactam: a \u03b2-lactam\/\u03b2-lactamase inhibitor combination","volume":"5","author":"Gin","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2015.04.015_bib2","first-page":"1641","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Benjamin","year":"2010","journal-title":"Rev Anti-infect Agents"},{"key":"10.1016\/j.jiac.2015.04.015_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchromb.2008.11.010","article-title":"High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin","volume":"877","author":"Di Giovamberardino","year":"2009","journal-title":"J\u00a0Chromatogr B Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.jiac.2015.04.015_bib4","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.44.8.2046-2051.2000","article-title":"A\u00a0population pharmacokinetic analysis of the penetration of the prostate by levofloxacin","volume":"44","author":"Drusano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2015.04.015_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-toolkit \u2013 a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.jiac.2015.04.015_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.04.015_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0732-8893(95)00053-D","article-title":"Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins","volume":"22","author":"Craig","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2015.04.015_bib8","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1086\/344653","article-title":"Prevention of resistance: a goal for dose selection for antimicrobial agents","volume":"36","author":"Drusano","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2015.04.015_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2005.04.013","article-title":"The role of antibiotics in chronic bacterial prostatitis","volume":"26","author":"Wagenlehner","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2015.04.015_bib10","first-page":"53","article-title":"Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009","volume":"64","author":"Yamaguchi","year":"2011","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jiac.2015.04.015_bib11","first-page":"73","article-title":"Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2008","volume":"65","author":"Yoshida","year":"2012","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jiac.2015.04.015_bib12","first-page":"71","article-title":"Clinical analysis and penetration of the bronchoalveolar area with panipenem\/betamipron (PAPM\/BP) in patients with chronic bronchitis","volume":"17","author":"Mori","year":"1998","journal-title":"Respir Res"},{"key":"10.1016\/j.jiac.2015.04.015_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1442-2042.1998.tb00597.x","article-title":"Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate","volume":"5","author":"Goto","year":"1998","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2015.04.015_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jac\/16.6.773","article-title":"The influence of prophylactic piperacillin on the postoperative course of transurethral prostatectomy","volume":"16","author":"Hoogkamp","year":"1985","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2015.04.015_bib15","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1093\/jac\/dks246","article-title":"Intrapulmonary penetration of ceftolozane\/tazobactam and piperacillin\/tazobactam in healthy adult subjects","volume":"67","author":"Chandorkar","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2015.04.015_bib16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1464-410X.2002.02991.x","article-title":"Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin\/tazobactam","volume":"90","author":"Cormio","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.jiac.2015.04.015_bib17","first-page":"32","article-title":"Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic\u2013pharmacodynamic evaluation","volume":"24","author":"Nakamura","year":"2012","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2015.04.015_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijantimicag.2012.11.001","article-title":"Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic\/pharmacodynamics evaluation","volume":"41","author":"Nishikawa","year":"2013","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15001087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X15001087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:53:37Z","timestamp":1761159217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X15001087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1341321X15001087"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2015.04.015","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Penetration of piperacillin\u2013tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2015.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}